STOCK TITAN

Armistice Capital/Steven Boyd disclose 6.75% stake in Bicycle Therapeutics (BCYC)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bicycle Therapeutics plc ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,398,000 American Depositary Shares, representing 6.75% of the class. The filing states Armistice Capital exercises shared voting and dispositive power over these shares as investment manager to a Master Fund.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake disclosure by an investment manager.

Armistice Capital is reported as the investment manager exercising shared voting and dispositive power over 3,398,000 ADS, equal to 6.75% of the class. The filing attributes beneficial ownership to the manager and to Steven Boyd as managing member.

The position is described as held through a Master Fund and governed by an Investment Management Agreement; the Master Fund disclaims direct voting/dispositive authority. Subsequent filings would update any change in holdings.

Shares beneficially owned 3,398,000 shares American Depositary Shares (ADS)
Percent of class 6.75% Percent of ADS class reported
CUSIP 088786108 ADS identifier in filing
American Depositary Shares financial
"Title: American Depositary Shares, each representing one ordinary share"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
Beneficially owned regulatory
"Item 4. Ownership (a) Amount beneficially owned: 3,398,000"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Investment Management Agreement legal
"Armistice Capital, as investment manager, pursuant to an Investment Management Agreement"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Armistice Capital report in BCYC?

Armistice Capital reports ownership of 3,398,000 ADS, or 6.75%. The filing states these ADS are held by a Master Fund for which Armistice Capital is the investment manager and over which it exercises shared voting and dispositive power.

Who is reported as the beneficial owner of the 3,398,000 shares?

Armistice Capital, LLC and Steven Boyd are the reporting persons. Armistice is the investment manager to the Master Fund (the direct holder); Steven Boyd is the managing member of Armistice Capital and is included in the joint filing.

Does the Master Fund claim voting or dispositive power over the shares?

The Master Fund disclaims direct voting or dispositive authority. The filing explains the Master Fund is the direct holder but, under its Investment Management Agreement, Armistice Capital exercises voting and investment power.

What class of security is covered by this Schedule 13G/A?

The filing covers American Depositary Shares (ADS), one ADS per ordinary share. The ADS have nominal value €0.01 per ordinary share and are identified by CUSIP 088786108 in the filing.

When was the joint filing signed?

The joint Schedule 13G/A amendment is signed May 15, 2026. Signatures are by Steven Boyd as Managing Member of Armistice Capital and as a reporting person in the joint filing statement included in the amendment.





088786108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:05/15/2026
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:05/15/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: May 15, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd